Advanced search
Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 14, 2002 - Issue 8
Submit an article Journal homepage
197
Views
65
CrossRef citations to date
0
Altmetric
Research Article

PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF STYRENE AND STYRENE OXIDE RESPIRATORY-TRACT DOSIMETRY IN RODENTS AND HUMANS

Ramesh Sarangapani The K. S. Crump Group, Inc., Research Triangle Park, North Carolina, USA
,
Justin G. Teeguarden The K. S. Crump Group, Inc., Research Triangle Park, North Carolina, USA
,
George Cruzan ToxWorks, Bridgeton, New Jersey, USA
,
Harvey J. Clewell ENVIRON International Corporation, Ruston, Louisiana, USA
&
Melvin E. Andersen Department of Environmental Health, Colorado State University, Ft. Collins, Colorado, USA
Pages 789-834 | Published online: 01 Oct 2008

  • Andersen, M. E., Clewell, H. J. IM, Gargas, M. L, Smith, F. A., and Reitz, R. H. 1987. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:185-205.
  • Andersen, M. E., Sarangapani, R., Frederick, C. B., and Kimbell, J. S. 1999. Dosimetric adjustment factors for methylmethacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model, lnhal. Toxicol. 11:899-926.
  • Anttila, S., Hirvonen, A., Vainio, H., Husgafvel-Pursiainen, K., Hayes, J. D., and Ketterer, B. 1993. lmmunohistochemical localization of giutathione S-transferases in human lung. Cancer Res. 53: 5643-5648.
  • Baron, J., and Voigt, J. 1990. Localization, distribution, and induction of xenobiotic-metabolizing enzymes and aryl hydrocarbon hydroxylase activity within lung. Pharmacol. Ther. 47:419-445.
  • Barton, H., Deisinger, P., English, J., Gearhart, J., Faber, W., Tyler, T., Banton, M., Teeguarden, J., and Andersen, M. 2000. Family approach for estimating reference concentrations/doses for series of related organic chemicals. Toxicol. Sci. 54:251-261.
  • Birnbaum, L. S., and Baird, M. B. 1979. Senescent changes in rodent hepatic epoxide metabolism. Chem. Biol. Interact. 26:245-256.
  • Bogdanffy, M. S., Sarangapani, R., Kimbell, J. S., Frame, R. S., and Plowchalk, D. R. 1998. Analysis of vinyl acetate metabolism in rat and human nasal tissues by an in vitro gas uptake technique. Toxicol. Sci. 46:235-246.
  • Bogdanffy, M. S., Sarangapani, R., Plowchalk, D. R., Jarabek, A., and Andersen, M. E. 1999. A biologically-based risk assessment for vinyl acetate-induced cancer and non-cancer inhalation toxicity. Toxicol. Sci. 51:19-35.
  • Bond, J. 1989. Review of the toxicology of styrene. Crit. Rev. Toxicol. 19:227-249.
  • Boorman, G. A., Montgomery, C. A., Jr., and MacKenzie, W. F., eds. 1990. Pathology of the Fischer rat: Reference and atlas. San Diego: Academic Press.
  • Brown, R. P., DeIp, M. D., Lindstedt, S. L., Rhomberg, L. R., and BeIiles, R. P. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13:407-484.
  • Butler, J., ed. 1992. The bronchial circulation. New York: Marcel Dekker.
  • Carlson, G. 1998. Metabolism of styrene oxide to styrene glycol by mouse liver and lung. J. Toxicol. Environ. Health 53:19-27.
  • Carlson, G., Hynes, D., and Mantick, N. 1998. Effects of inhibitors of CYP1A and CYP2B on styrene metabolism in mouse liver and lung microsomes. Toxicol. Lett. 98:131-137.
  • Chang, H. K., and Paiva, M. 1989. Respiratory physiology: An analytical approach. New York: Marcel Dekker.
  • Clewell, H. J. 3rd, Gentry, P. R., Covington, T. R., and Gearhart, J. M. 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108(suppl.2):283-305.
  • Cook, J., Pass, H., lype, S., Friedman, N., DeGraff, W., Russo, A., and Mitchell, J. 1991. Cellular giutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res. 51:4287-4294.
  • Coursin, D., Cihla, H., Oberley, T., and Oberley, W. L. 1992. Immunolocalization of antioxidant enzymes and isozymes of giutathione S-transferase in normal rat lung. Am. J. Physiol. 263:1.679-L691.
  • Cruzan, G., Cushman, J., Andrews, L., Granville, G., Johnson, K., Hardy, C, Coombs, D., Mullins, P., and Brown, W. 1998. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol. Sci. 46:266-281.
  • Cruzan, G., Cushman, J. R., Andrews, L. S., Granville, G. C., Johnson, K. A., Bevan, C., Hardy, C. J., Coombs, D. W., Mullins, P. A., and Brown, W. R. 2001. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J. Appl. Toxicol. 21:185-98.
  • Csanady, G., Mendrala, A., Nolan, R., and Filser, J. 1994. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch. Toxicol. 68:143-157.
  • Cussler, E. L. 1999. Diffusion: Mass transfer in fluid systems. Cambridge, UK: Cambridge University Press.
  • Deutschmann, S., and Laib, R. 1989. Concentration-dependent depletion of non-protein sulfhydryl (NPSH) content in lung, heart and liver tissue of rats and mice after acute inhalation exposure to butadiene. Toxicol. Lett. 45:175-183.
  • D'Souza, R. W., Francis, W. R., and Andersen, M. E. 1988. Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. J. Pharmacol. Exp. Ther. 245:563-568.
  • Filser, J. G., Schwegler, U., Csanady, G. A., Greim, H., Kreuzer, P. E., and Kessler, W. 1993. Species-specific pharmacokinetics of styrene in rat and mouse. Arch. Toxicol. 67:517-530.
  • Frederick, C. B., Bush, M. L., Lomax, L. G., Black, K. A., Finch, L., Kimbell, J. S., Morgan, K. T., Subramaniam, R. P., Morris, J. B., and Ultman, J. S. 1998. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol. Appl. Pharmacol. 152:211-231.
  • Gadberry, M., DeNicola, D., and Carlson, G. 1996. Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. J. Toxicol. Environ. Health 48:273-294.
  • Gargas, M. L., Burgess, R. J., Voisard, D. E., Cason, G. H., and Andersen, M. E. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98:87-99.
  • Green, T. 1995. Methylene chloride induced mouse liver and lung tumours. Arderley Park, Maccles-field, Cheshire, UK: Zeneca, Central Toxicology Laboratory.
  • Green, T. 1999. Styrene: A 10 day inhalation study to investigate effects of mouse and rat lung. Alderley Park, Macclesfidd, Cheshire, UK: Zeneca Central Toxicology Laboratory.
  • Green, T. 2000. Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action. Environ. Health Perspect. 108(suppl.2):261-264.
  • Green, T., Mainwaring, G. W., and Foster, J. R. 1997. Trichloroethylene-induced mouse lung tumors: Studies of the mode of action and comparisons between species. Fundam. Appl. Toxicol. 37:125-130.
  • Griffeth, L. K., Rosen, G. M., and Rauchman, E. J. 1987. Effects of model traumatic injury on hepatic drug metabolism in the rat. Vl. Major detoxification/toxification pathways. Drug Metab. Dispos. 15:749-759.
  • Hiratsuka, A., Yokoi, A., Iwata, H., Watabe, T., Satoh, K., Hatayama, I., and Sato, K. 1989. Glutathione conjugation of styrene 7,8-oxide enantiomers by major glutathione transferase isoenzymes isolated from rat livers. Biochem. Pharmacol. 38:4405-4413.
  • Hynes, D. E., DeNicola, D. B., and Carlson, G. P. 1999. Metabolism of styrene by mouse and rat isolated lung cells. Toxicol. Sci. 51:195-201.
  • ICRP. 1994. Human respiratory tract model for radiological protection: A report of a task group of the International Commission on Radiological Protection. Oxford, UK: Elsevier Sciences, Ltd.
  • Jeffery, P. K., and Reid, L. 1975. New observations of rat airway epithelium: A quantitative and electron microscopic study. J. Anat. 120:295-320.
  • Johanson, G., Emstgard, L, Gullstrand, E., Lof, A., Osterman-Golkar, S., Williams, C. C., and Sumner, S. C. 2000. Styrene oxide in blood, hemoglobin adducts, and urinary metabolites in human volunteers exposed to (13)C(8)-styrene vapors. Toxicol. Appl. Pharmacol. 168:36-49.
  • Johanson, G., and Riser, J. G. 1992. Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Arch. Toxicol. 66:291-295.
  • Johanson, G., and Filser, J. G. 1993. A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation. Arch. Toxicol. 67:151-163.
  • Jones, K., Holland, J., Foureman, G., Bend, J., and Fouts, J. 1983. Xenobiotic metabolism in Clara cells and alveolar type Il cells isolated from lungs of rats treated with beta-naphthoflavone. J. Pharmacol. Exp. Ther. 225:316-319.
  • Linhart, I., Gut, I., Smejkal, J., and Novak, J. 2000. Biotransformation of styrene in mice. Stereochemical aspects. Chem. Res. Toxicol. 13:36-44.
  • Lof, A., Gullstrand, E., Lundgren, E., and Nordqvist, M. B. 1984. Occurrence of styrene-7,8-oxide and styrene glycol in mouse after the administration of styrene. Scand. J. Work. Environ. Health 10: 179-187.
  • Lu, S. C. 1999. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13:1169-1183.
  • Mace, K., Bowman, E. D., Vautravers, P., Shields, P. G., Hams, C. C., and Pfeifer, A. M. 1998. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34:914-920.
  • Maltoni, C., Cotti, G., and Perino, G. 1988. Long-term carcinogenicity bioassays on methylene chloride administered by ingestion to Sprague-Dawley rats and Swiss mice and by inhalation to Sprague-Dawley rats. Ann. NY Acad. Sci. 534:352-366.
  • Massaro, E. J. 1997. Handbook of human toxicology. Boca Raton, FL: CRC Press.
  • McConnell, E., and Swenberg, J. 1994. Review of styrene and styrene oxide long-term animal studies. Crit. Rev. Toxicol. 24:S49-S55.
  • Melnick, R. L, Shackelford, C. C., and Huff, J. 1993. Carcinogenicity of 1,3-butadiene. Environ. Health Perspect. 100:227-236.
  • Menache, M., Hanna, L, Gross, E., Lou, S., Zinreich, S., Leopold, D., Jarabek, A., and Miller, F. 1997. Upper respiratory tract surface areas and volumes of laboratory animals and humans: Considerations for dosimetry models. J. Toxicol. Environ. Health 50:475-506.
  • Mendrala, A. L, Langvardt, P. W., Nitschke, K. D., Quast, J. F., and Nolan, R. J. 1993. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch. Toxicol. 67:18-27.
  • Mercer, R. R., Russell, M. L., Roggli, V. L., and Crapo, J. D. 1994. Cell number and distribution in human and rat airways. Am. J. Respir. Cell MoI. Biol. 10:613-24.
  • Miller, R., Newhook, R., and Poole, A. 1994. Styrene production, use, and human exposure. Crit. Rev. Toxicol. 24:S1-S10.
  • Morgan, D. L, Mahler, J. F., Dill, J. A., Price, H. C., Jr., O'Connor, R. W., and Adkins, B., Jr. 1993. Styrene inhalation toxicity studies in mice. III. Strain differences in susceptibility. Fundam. Appl. Toxicol. 21:326-333.
  • Morris, J. B. 2000. Uptake of styrene in the upper respiratory tract of the CD mouse and Sprague-Dawley rat. Toxicol. Sci. 54:222-228.
  • Nakajima, T., Elovaara, E., Gonzalez, F. J., Gdboin, H. V., Raunio, H., Pelkonen, O., Vainio, H., and Aoyama, T. 1994. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem. Res. Toxicol. 7:891-896.
  • Oesch, F., Zimmer, A., and Glatt, H. R. 1983. Microsomal epoxide hydrolase in different rat strains. Biochem. Pharmacol. 32:1783-1788.
  • Oldham, M., Phalen, R., Schum, G., and Daniels, D. 1994. Predicted nasal and tracheobronchial particle deposition efficiencies for the mouse. Ann. Occup. Hyg. 38:135-141.
  • Pacifici, G. M., Boobis, A. R., Brodie, M. J., McManus, M. E., and Davies, D. S. 1981. Tissue and species differences in enzymes of epoxide metabolism. Xenobiotica 11:73-79.
  • Pacifici, G., Warholm, M., Guthenberg, C, Mannervik, B., and Rane, A. 1987. Detoxification of styrene oxide by human liver glutathionetransferase. Hum. Toxicol. 6:483-489.
  • Pacifici, G. M., Franchi, M., Bencini, C, Repetti, F., Di Lascio, N., and Muraro, G. B. 1988. Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 18:849-856.
  • Pack, R. J., Al-Ugaily, L H., and Morris, G. 1981. The cells of the tracheobronchial epithelium of the mouse: A quantitative light and electron microscope study. J. Anat. 132:71-84.
  • Parent, R. A., ed. 1992. Treatise on pulmonary toxicology. Boca Raton, FL: CRC Press.
  • Paulsson, B., Bende, M., and Ohlin, P. 1985. Nasal mucosal blood flow at rest and during exercise. Acta Otolaryngol. 99:140-143.
  • Plopper, C, and Hyde, D. 1992. Epithelial cells of bronchioles. In Treatise on pulmonary toxicology. Comparative biology of the normal lung, ed. R. Parent, pp. 131-143. Boca Raton, FL: CRC Press.
  • Plopper, C. G., Hill, L. H., and Mariassy, A. T. 1980a. Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung. III. A study of man with comparison of 15 mammalian species. Exp. Lung Res. 1:171-180.
  • Plopper, C. G., Hyde, D. M., and Buckpitt, A. R. 1991. Clara cells. In The lung: Scientific foundations, eds. R. G. Crystal and J. B. West, pp. 517-534. New York: Raven Press.
  • Plopper, C. G., Macklin, J., Nishio, S. J., Hyde, D. M., and Buckpitt, A. R. 1992. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene. Lab. Invest. 67:553-565.
  • Plopper, C. G., Mariassy, A. T., and Hill, L. H. 1980b. Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung: I. A comparison of rabbit, guinea pig, rat, hamster, and mouse. Exp. Lung Res. 1:139-154.
  • Potter, D. W., and Tran, T. B. 1993. Apparent rates of glutathione turnover in rat tissues. Toxicol. Appl. Pharmacol. 120:186-192.
  • Ramsey, J. C., and Andersen, M. E. 1984. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:159-175.
  • Ramsey, J. C, and Young, J. D. 1978. Pharmacokinetics of inhaled styrene in rats and humans. Scand. J. Work. Environ. Health 4:84-91.
  • Sato, A., and Nakajima, T. 1979. A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol. 47:41-46.
  • Schladt, L., Thomas, H., Hartmann, R., and Oesch, F. 1988. Human liver cytosolic epoxide hydrolases. Eur. J. Biochem. 176:715-723.
  • Seidegard, J., DePierre, J. W., Moron, M. S., Johannesen, K. A., and Ernster, L. 1977. Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity. Cancer Res. 37:1075-1082.
  • SIRC. 1999. A toxicological review of styrene. Arlington, VA: U.S. EPA NCEA.
  • Smith, B. R., Maguire, J. H., Ball, L. M., and Bend, J. R. 1978. Pulmonary metabolism of epoxides. Fed. Proc. 37:2480-4284.
  • Stone, K. C., Mercer, R. R., Gehr, P., Stockstill, B., and Crapo, J. D. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell MoI. Biol. 6:235-243.
  • Stoner, G. D. 1998. Introduction to mouse lung tumorigenesis. Exp. Lung Res. 24:375-383.
  • Stott, W., Dryzga, M., and Ramsey, J. 1983. Blood-flow distribution in the mouse. J. Appl. Toxicol. 3:310-312.
  • Stott, W. T., Ramsey, J. C., and McKenna, M. J. 1986. Absorption of chemical vapors by the upper respiratory tract of rats. In Toxicology of the nasal passages, ed. C. S. Burrows, pp. 191-210. Washington, DC: Hemisphere.
  • Sumner, S., and Fennell, T. 1994. Review of the metabolic fate of styrene. Crit. Rev. Toxicol. 24:S11-S33.
  • Sweeney, L. M., Himmelstein, M. W., Schlosser, P. M., and Medinsky, M. A. 1996a. Physiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadiene. Toxicology 113:318-21.
  • Sweeney, L. M., Shuler, M. L., Quick, D. J., and Babish, J. G. 1996b. A preliminary physiologically based pharmacokinetic model for naphthalene and naphthalene oxide in mice and rats. Ann. Biomed. Eng. 24:305-320.
  • U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Washington, DC: Office of Health and Environmental Assessment.
  • U.S. Environmental Protection Agency. 1996. Proposed guidelines for carcinogen risk assessment. Washington, DC: Office of Research and Development.
  • U.S. Environmental Protection Agency. 1999. Review of the USEPA 1996 proposed guidelines for carcinogen risk assessment. Prepared by Science Advisory Board. Washington, DC: Office of Research and Development.
  • Waechter, F., Bentley, P., Bieri, F., Muakkassah-Kelly, S., Staubli, W., and Villermain, M. 1988. Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopintreated male DBA/2 mice. Biochem. Pharmacol. 37:3897-3903.
  • Watabe, T., Ozawa, N., and Hiratsuka, A. 1983. Studies on metabolism and toxicity of styrene-VI. Regiosdectivity in glutathione S-conjugation and hydrolysis of racemic, R- and S-phenyloxiranes in rat liver. Biochem. Pharmacol. 32:777-785.
  • Wenker, M. A., Kezic, S., Monster, A. C., and de Wolff, F. A. 2000. Metabolism of styrene-7,8-oxide in human liver in vitro: Interindividual variation and stereochemistry. Toxicol. Appl. Pharmacol. 169: 52-58.
  • Withey, J. R., and CoIIins, P. G. 1979. The distribution and pharmacokinetics of styrene monomer in rats by the pulmonary route. J. Environ. Pathol. Toxicol. 2:1329-1342.
  • Yeh, H. C., and Schum, G. M. 1980. Models of human lung airways and their application to inhaled particle deposition. Bull. Math. Biol. 42:461-480.
  • Yeh, H. C., Schum, G. M., and Duggan, M. T. 1979. Anatomic models of the tracheobronchial and pulmonary regions of the rat. Mat. Rec. 195:483-492.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.